Indivior Pharmaceuticals, Inc. (E7P)
XDUS
30.80
-0.80 (-2.53%)
Real-time Data
06:00 AM
Day's Range
30.6031.00
52 wk Range
14.3036.60
Financial Statements - E7P - Indivior Pharmaceuticals, Inc.
Revenue
1.23B
Net Income
210.00MNet Margin 16.9%
EBITDA
307.00M
Free Cash Flow
-94.00M
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 1.23B |
| Cost of Goods | 246M |
| Gross Profit | 993M |
 Operating Expense | - |
| Operating Income | 265M |
| Non-Operating Interest | - |
| Other Income Expense | -3M |
| Pre Tax Income | 239M |
| Income Tax | 29M |
| Net Income | 210M |
| EPS Basic | 1.68 |
| EPS Diluted | 1.64 |
| Basic Shares Outstanding | 125M |
| Diluted Shares Outstanding | 125M |
| Ebit | 284M |
| Ebitda | 307M |
| Net Income Continuous Operations | 210M |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
